Home / Health / Weight Loss Jabs May Fight Cancer, Study Hints
Weight Loss Jabs May Fight Cancer, Study Hints
3 Jun
Summary
- Weight loss drugs might reduce inflammation and impact tumour growth.
- Research presented at ASCO suggests potential cancer benefits.
- Experts call for trials to confirm anti-cancer effects of GLP-1 drugs.
Emerging research indicates that weight loss medications, such as Wegovy and Mounjaro, might offer benefits beyond weight management, potentially inhibiting tumor growth through reduced inflammation and other metabolic actions. These findings were presented at the American Society of Clinical Oncology's annual conference.
Further studies suggest a link between these GLP-1 drugs and a reduced risk of mortality in breast cancer patients. Additionally, they may provide a protective effect against pancreatic and lung cancer for individuals at high risk.
Experts, however, urge caution. While acknowledging a growing signal of positive effects, they stress that current data is observational and cannot prove cancer prevention. Rigorous clinical trials are deemed essential to fully understand and confirm these potential anti-cancer properties before making broad recommendations.
